Search Tag: Hologic
Hologic Launches Fluoroscan® InSight™ FD Mini C-Arm Extremities Imaging System
2018 26 Jan
Hologic, Inc. today announced the launch of the next generation in mini C-arm imaging, the Fluoroscan® InSight™ FD Mini C-Arm, the latest product illustrating the Company’s commitment to addressing the continuum of skeletal health care. The enhanced system adds to Hologic’s portfolio of market-leading skeletal imaging solutions. It offers... Read more
Hologic Announces European CE Mark for Brevera® Breast Biopsy System with CorLumina®
2018 09 Jan
Transformational Workflow Solution Offers Real-Time Imaging of Tissue Samples, Resulting in Major Cost and Time Savings Hologic, Inc. today announced it has obtained a CE Mark in Europe for the Brevera® breast biopsy system with CorLumina® imaging technology, a groundbreaking real-time breast biopsy and verification system that improves... Read more
Hologic selected for Dutch Breast Cancer Screening Program
2017 02 Nov
Under the tender, state-of-the-art 3DimensionsTM mammography systems will be installed starting in 2018 Hologic, Inc. has announced that it will provide all mammography systems for the Dutch Breast Cancer Screening Program in partnership with Tromp Medical, Hologic’s distributor in the Netherlands. Under the tender, Hologic’s new, state-of-the-art... Read more
Reinventing breast tomosynthesis
2017 30 Oct
Expanding leadership based on clinical evidence In early September, Hologic launched the new 3Dimensions™ mammography system , a breast tomosynthesis system with the fastest and highest resolution, in EMEA. I recently had the pleasure of showcasing this cutting-edge device at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting,... Read more
Paraflu Assay Now FDA Cleared on Hologic's New Panther Fusion® System
2017 26 Oct
-- New Assay Extends Respiratory Testing Menu; Modular Panels and Fusion System Increase Efficiency and Flexibility for the Laboratory – Hologic, Inc. announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Panther Fusion® Paraflu assay, a multiplexed assay which runs on the... Read more
Hologic Receives CE Mark to Market SculpSure® for Non-Invasive Body Contouring of the Submental Area
2017 19 Oct
Patients in Clinical Studies Report 100% Satisfaction Hologic, Inc. has announced that it has received an additional European Medical Device Directive (MDD) certification for SculpSure®, a state-of-the-art body contouring laser treatment. The device is now certified to treat a double chin (also known as the submental area), marking the product's... Read more
Panther Fusion® Flu A/B/RSV Assay Now FDA Cleared on Hologic's New Panther Fusion® System
2017 06 Oct
- New Panther Fusion Module Expands System's Molecular Testing Capabilities, Increases Efficiency and Flexibility for the Laboratory Hologic, Inc. has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Panther Fusion® Flu A/B/RSV assay running on the new Panther Fusion® system. ... Read more
Hologic enters into amended and restated five-year secured credit agreement
2017 04 Oct
- Initial Proceeds from New $1.5 Billion Term Loan and $1.5 Billion Revolving Credit Line Used to Refinance Senior Secured Debt - - Funds Also Expected to Contribute to Retirement of Remaining Convertible Notes - Hologic, Inc.has announced that the Company has entered into an amended and restated credit agreement consisting of a new, five-year $1.5... Read more
Hologic announces offering of $350 Million of Senior Notes due 2025
2017 04 Oct
- Proceeds Expected to Contribute to Retirement of Remaining Convertible Notes - Hologic, Inc. has announced that it has launched, subject to market and other conditions, a private offering of $350 million aggregate principal amount of senior notes due 2025. Hologic intends to use the proceeds of the offering and available cash,... Read more
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2017
2017 03 Oct
Hologic, Inc. has announced that the Company plans to release its financial results for the fourth quarter of fiscal 2017 on Wednesday, November 8, 2017 after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing... Read more